MedPath

The effect of nanostructures of Latanoprost on male pattern hair loss

Phase 3
Recruiting
Conditions
Androgenic alopecia.
Androgenic alopecia
Registration Number
IRCT20211209053339N1
Lead Sponsor
Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Male
Target Recruitment
16
Inclusion Criteria

Male gender
Age between 23 to 50 years
manifestations of androgenic hair loss

Exclusion Criteria

History of skin cancer
History of physical therapy on the scalp during the last 6 months
Manifestations of skin disease in the desired area
History of hair transplantation

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hair diameter. Timepoint: Before starting treatment and also at weeks 4, 8, 12, 16, 20 and 24. Method of measurement: Trichoscope.;Hair color. Timepoint: Before starting treatment and also at weeks 4, 8, 12, 16, 20 and 24. Method of measurement: Trichoscope.;Hair density. Timepoint: Before starting treatment and also at weeks 4, 8, 12, 16, 20 and 24. Method of measurement: Trichoscope.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath